HIGHLIGHTS
- who: Aliya Anil et al. from the Affiliated Hospital of Guizhou Medical University, China have published the paper: Identification of single-dose, dual-echo based CBV threshold for fractional tumor burden mapping in recurrent glioblastoma, in the Journal: (JOURNAL)
- what: The authors determine optimum rCBV thresholds for the single-dose, dual-echo DSC-MRI approach to generate FTB maps that distinguish tumor and PTRE and best match with the reference standard, double-dose, single-echo FTB map. This study shows that the single-dose, dualecho protocol can be reliably used to distinguish tumor and PTRE . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.